Bispecific molecules which react both with the high-affinity Fcγ receptor of human effector
cells and with a target cell surface antigen are disclosed. Binding of the molecules to the Fc …

Monoclonal antibodies which react specifically to Fc receptor of human effector cells are
disclosed. Binding of the antibodies to the receptor is not blocked by human immunoglobulin …

C07K16/283—Immunoglobulins [IGs], eg monoclonal or polyclonal antibodies against
material from animals or humans against receptors, cell surface antigens or cell surface …

Monoclonal antibodies which react speci? cally to Fe recep tor of human eifector cells IgG
are disclosed. Binding of the antibodies to the receptor is not blocked by human immu …

In one aspect, the invention relates to a bispecific mol ecule comprising a target cell Specific
ligand and an antibody or functional antibody fragment Specific for an effector cell. In a …

US5624821A - Antibodies with altered effector functions - Google Patents US5624821A -
Antibodies with altered effector functions - Google Patents Antibodies with altered effector …

US6410690B1 - Therapeutic compounds comprised of anti-Fc receptor antibodies - Google
Patents US6410690B1 - Therapeutic compounds comprised of anti-Fc receptor antibodies …

US5837243A - Therapeutic compounds comprised of anti-Fc receptor antibodies - Google
Patents US5837243A - Therapeutic compounds comprised of anti-Fc receptor antibodies …

This invention pertains to a binding agent which binds a Surface receptor of an antigen-
presenting cell in Some instances without being blocked Substantially by the natural ligand …

The present invention relates to a method for the production and the selection of human or
chimæric or humanized antibodies or molecules that comprise the Fc region of human IgG …